The delay, narrowed approval, and extra study steps raise concerns about the status of and potential added requirements for other COVID vaccines.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
US adults who get the flu vaccine every year are 24.7% more likely to complete a primary COVID-19 vaccine regimen.
Relative vaccine effectiveness of a second booster dose against severe COVID-19 is only about 30% after 2 to 4 months in people 80 and older, compared with one booster dose.
60% of hospitalized COVID patients and 68% of those not hospitalized had at least one symptom 2 years later.
The report reveals encouraging investments but also persistent COVID-19 vaccine inequity and a nearly vacant pipeline for products to treat or prevent emerging pathogens that have pandemic potential.
Veterans with mild to moderate infections seen as outpatients underused therapies, including monoclonal antibodies and antivirals
Both of its updated Omicron boosters against Omicron prompt a strong antibody response.
A UK study suggests that Omicron BA.2 is tied to more symptoms and impeded daily activities than BA.1, and Taiwanese researchers describe fatal cerebral edema in 6 kids with BA.2.
The sensitivities of 3 commonly used rapid antigen tests were very low for Omicron in asymptomatic people.
A study today in BMC Medicine highlights the toll that the COVID-19 pandemic has taken on the diagnosis of tuberculosis (TB) in high-burden countries, particularly in vulnerable populations.
Two of the 4 new studies show that SARS-CoV-2 can profoundly damage the brain for months.
